These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 22486964)
1. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma. Ling Y; Wei K; Zou F; Zhong S Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964 [TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment. Ramalho MJ; Sevin E; Gosselet F; Lima J; Coelho MAN; Loureiro JA; Pereira MC Int J Pharm; 2018 Jul; 545(1-2):84-92. PubMed ID: 29715532 [TBL] [Abstract][Full Text] [Related]
3. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats. Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669 [TBL] [Abstract][Full Text] [Related]
4. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
5. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
6. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells. Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568 [TBL] [Abstract][Full Text] [Related]
7. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles. Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660 [TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
9. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy. Mao J; Meng X; Zhao C; Yang Y; Liu G Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310 [TBL] [Abstract][Full Text] [Related]
10. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies. Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy. Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991 [TBL] [Abstract][Full Text] [Related]
12. Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: development, characterization and in vivo studies. Jain D; Bajaj A; Athawale R; Shrikhande S; Goel PN; Nikam Y; Gude R; Patil S; Prashant Raut P Drug Deliv; 2016; 23(3):999-1016. PubMed ID: 25026415 [TBL] [Abstract][Full Text] [Related]
13. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas. Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701 [TBL] [Abstract][Full Text] [Related]
14. The effect of temozolomide/poly(lactide-co-glycolide) (PLGA)/nano-hydroxyapatite microspheres on glioma U87 cells behavior. Zhang D; Tian A; Xue X; Wang M; Qiu B; Wu A Int J Mol Sci; 2012; 13(1):1109-1125. PubMed ID: 22312307 [TBL] [Abstract][Full Text] [Related]
15. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles. Muñoz-Gámez JA; López Viota J; Barrientos A; Carazo Á; Sanjuán-Nuñez L; Quiles-Perez R; Muñoz-de-Rueda P; Delgado Á; Ruiz-Extremera Á; Salmerón J Liver Int; 2015 Apr; 35(4):1430-41. PubMed ID: 24821649 [TBL] [Abstract][Full Text] [Related]
16. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging. Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087 [TBL] [Abstract][Full Text] [Related]
17. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release]. Li JL; Zheng CL; Liu JP; Zhu JB Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702 [TBL] [Abstract][Full Text] [Related]
18. Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging. Schleich N; Sibret P; Danhier P; Ucakar B; Laurent S; Muller RN; Jérôme C; Gallez B; Préat V; Danhier F Int J Pharm; 2013 Apr; 447(1-2):94-101. PubMed ID: 23485340 [TBL] [Abstract][Full Text] [Related]
19. Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy. Ling Y; Wei K; Luo Y; Gao X; Zhong S Biomaterials; 2011 Oct; 32(29):7139-50. PubMed ID: 21726899 [TBL] [Abstract][Full Text] [Related]
20. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations. Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]